Skip to main content
Centrum Capital Limited logo

Centrum Capital Limited — Investor Relations & Filings

Ticker · CENTRUM ISIN · INE660C01027 LEI · 3358003PSYKBJMT6F508 BSE.NS Financial and insurance activities
Open in API
Filings indexed 1,206 across all filing types
Latest filing 2023-12-22 Regulatory Filings
Country IN India
Listing BSE.NS CENTRUM

About Centrum Capital Limited

https://www.centrum.co.in/

Centrum Capital Limited provides a comprehensive suite of financial solutions encompassing investment banking, wealth management, and institutional equities. The firm specializes in advisory services for equity and debt capital markets, mergers and acquisitions, and structured finance. Its operational framework includes specialized lending arms focused on the SME, MSME, and retail segments, offering microfinance and housing finance products. Serving a diverse clientele of corporations, institutional investors, and high-net-worth individuals, the organization leverages an integrated platform to deliver strategic capital raising and investment management services. The group’s value proposition is built on deep domain expertise and a robust distribution network designed to facilitate complex financial transactions and wealth preservation.

Recent filings

Filing Released Lang Actions
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal notice addressed to stock exchanges informing about an upcoming Board of Directors meeting scheduled for February 9, 2024. The purpose of the meeting is to consider and approve the unaudited financial results for the quarter and nine months ended December 31, 2023. It also mentions the closure of the trading window in accordance with the company's code of conduct. The document does not contain any financial data or results itself but is an announcement of the meeting where such results will be approved. The document length is short (2221 characters) and it serves as an intimation under SEBI regulations about the board meeting and trading window closure. Therefore, this is a Regulatory Filing (RNS) as it is a general regulatory announcement and does not contain the actual financial report or results.
2023-12-22 English
Board Meeting — CENTRUM CAPITAL LIMITED has informed the Exchange about Board Meeting to be held on 09-Feb-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for t…
Regulatory Filings
2023-12-22 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a formal notice addressed to stock exchanges informing about an upcoming Board of Directors meeting scheduled for February 9, 2024. The purpose of the meeting is to consider and approve the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2023. It also mentions the closure of the trading window in accordance with the company's code of conduct. The document does not contain the financial results themselves but is an announcement of the meeting where these results will be approved. The document length is short (2221 characters) and it serves as an intimation or notice rather than the actual financial report. Therefore, it fits the category of Regulatory Filings (RNS) as a general regulatory announcement under SEBI regulations, rather than an Interim Report (IR) or Earnings Release (ER).
2023-12-22 English
CENTRUM CAPITAL LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2024 ,inter alia, to consider and approve This is to inform you that, ....
Regulatory Filings Classification · 95% confidence The document is a formal notice addressed to stock exchanges about an upcoming Board of Directors meeting scheduled for February 9, 2024. The purpose of the meeting is to consider and approve the unaudited financial results for the quarter and nine months ended December 31, 2023. It also mentions the closure of the trading window in accordance with the company's code of conduct. The document does not contain the financial results themselves but is an announcement of the meeting where these results will be approved. The document length is short (2221 characters) and it serves as an intimation or notice rather than the actual financial report. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement under SEBI regulations, not an Interim Report (IR) or Earnings Release (ER).
2023-12-22 English
The Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on December 15, 2023 for Business ....
Regulatory Filings
2023-12-15 English
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on December 11, 2023 for Business Match Services ....
Regulatory Filings
2023-12-11 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.